Home
About
Overview
Sharing Data
ORCID
Help
History (22)
Ending the 50-year drought of FDA drug approval for SLE.
Teratoma
Immediate Dental Implant Loading
Monocyte metabolic reprogramming promotes pro-inflammatory activity and Staphylococcus aureus biofilm clearance.
Efficacy and safety of abatacept in lupus nephritis: a twelve-month, randomized, double-blind study.
See All 22 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Efficacy and safety of abatacept in lupus nephritis: a twelve-month, randomized, double-blind study.
Efficacy and safety of abatacept in lupus nephritis: a twelve-month, randomized, double-blind study. Arthritis Rheumatol. 2014 Feb; 66(2):379-89.
View in:
PubMed
subject areas
Abatacept
Adult
Dose-Response Relationship, Drug
Double-Blind Method
Female
Humans
Immunoconjugates
Immunosuppressive Agents
Internationality
Longitudinal Studies
Lupus Nephritis
Male
Severity of Illness Index
Treatment Outcome
authors with profiles
Joan Merrill